Explore

Trendline Trendline
OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning

OneCyte and Kemp Proteins Partner to Enhance Cell Line Development with Machine Learning
Trendline Trendline
Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges

Augmented Intelligence Revolutionizes Biopharma Innovation Amid Investment Challenges
Trendline Trendline
Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences

Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences

Anthropic Acquires Coefficient Bio to Expand AI in Life Sciences
Trendline Trendline
AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs

AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs

AI Revolutionizes Biotech Industry Amidst IT Sector Layoffs
Trendline Trendline
API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development

API's Lean Derisking Strategy Aims to Streamline Drug Development
Trendline Trendline
API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'

API's Strategic Approach to Drug Development Aims to Overcome 'Valley of Death'
Trendline Trendline
Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery

Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery

Anima Biotech Introduces BioGPU to Enhance AI-Driven Drug Discovery
Trendline Trendline
Decoy Therapeutics to Present Business Outlook at Virtual Investor Event

Decoy Therapeutics to Present Business Outlook at Virtual Investor Event

Decoy Therapeutics to Present Business Outlook at Virtual Investor Event
Trendline Trendline
FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma

FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma

FDA Decision on Replimune's RP1 Drug Could Signal Regulatory Direction for Biopharma
Trendline Trendline
Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration

Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration

Regeneron and TriNetX Collaborate to Enhance Genomic and Health Data Integration
Trendline Trendline
Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines

Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines

Aspect Biosystems Secures $280 Million Partnership with Canadian Government to Boost Bioengineered Medicines
Trendline Trendline
BioNTech to Close Singapore mRNA Facility Amid Strategic Shift

BioNTech to Close Singapore mRNA Facility Amid Strategic Shift

BioNTech to Close Singapore mRNA Facility Amid Strategic Shift